TP53 and cancer: Many 2-sulfonyl pyrimidine compounds, such as PK11007 and PK11000, are successful in killing cancer cells by explicitly attacking mutant P53 thiol groups, thereby reducing oxidative stress levels (e.g., ROS) and eventually retaining a redox state [94,95].